Serum enzyme levels in patients with myasthenia gravis after aerobic and ischaemic exercise1

This study was designed to test the hypothesis that there is a myopathic component in myasthenia gravis. Serum enzyme analyses and lactate and pyruvate assays were undertaken before and after exercise in order to detect possible leakage from defective muscle membrane. A patient and a control group were exercised under (1) aerobic conditions, (2) ischaemic conditions, and (3) aerobic conditions under the influence of edrophonium chloride. The patient group showed a higher resting level of lactate in the aerobic state than did the controls. In addition, the average change in SGOT values in the patient group after one minute of aerobic exercise under the influence of edrophonium chloride exceeded that of the control group. Both these findings suggest possible leakage of enzyme and metabolite from the myasthenic muscle due to a membrane defect and support the hypothesis that there may be a myopathic component in myasthenia gravis. However, the two groups showed no significant differences in CPK values, which are often elevated in primary muscle diseases.

[1]  D. Grob,et al.  Myasthenia gravis: effect of the serum and serum globulin on neuromuscular transmission. , 1968, Neurology.

[2]  L. Wilkins.  General Scientific Session , 1968, Neurology.

[3]  A. J. Strauss,et al.  Serum autoantibodies in myasthenia gravis and thymoma: selective affinity for I-bands of striated muscle as a guide to identification of antigen(s). , 1967, Journal of immunology.

[4]  C. Herrmann.  Myasthenia gravis: brief guide to diagnosis and management. , 1967, California medicine.

[5]  H. Reese,et al.  PYRUVIC AND LACTIC ACID METABOLISM IN MUSCULAR DYSTROPHY, NEUROPATHIES AND OTHER NEUROMUSCULAR DISORDERS , 1967, The American journal of the medical sciences.

[6]  D. McFarlin,et al.  DOES MYASTHENIC SERUM BIND TO THE NEUROMUSCULAR JUNCTION? , 1966, Annals of the New York Academy of Sciences.

[7]  J. Simpson,et al.  MYASTHENIA GRAVIS AS AN AUTOIMMUNE DISEASE: CLINICAL ASPECTS , 1966, Annals of the New York Academy of Sciences.

[8]  J. Hess.  Phosphorylase activity and glycogen, glucose-6-phosphate, and lactic acid content of human skeletal muscle in various myopathies. , 1965, The Journal of laboratory and clinical medicine.

[9]  W. Dameshek.  AUTOIMMUNITY: THEORETICAL ASPECTS * , 1965, Annals of the New York Academy of Sciences.

[10]  J. Hess,et al.  SERUM CREATINE PHOSPHOKINASE (CPK) ACTIVITY IN DISORDERS OF HEART AND SKELETAL MUSCLE. , 1964, Annals of internal medicine.

[11]  B. Seegal,et al.  Immunofluorescence Demonstration of a Muscle Binding, Complement-Fixing Serum Globulin Fraction in Myasthenia Gravis. ∗ , 1960 .

[12]  J. Simpson.  Myasthenia Gravis: A New Hypothesis , 1960 .

[13]  Fleisher Ga,et al.  The clinical significance of serum aldolase. , 1954 .

[14]  S. Wray,et al.  Auto-immune aspects of myasthenia gravis. , 1966, The Quarterly journal of medicine.

[15]  J. Simpson.  The Biochemistry of Myasthenia Gravis , 1966 .

[16]  G. Fleisher,et al.  The clinical significance of serum aldolase. , 1954, Proceedings of the staff meetings. Mayo Clinic.